Collateral Immune Cell Signaling Compromises the Efficacy of T-cell Engaging Therapies for Cardiac Fibrosis
Steven Hoseong Yang, Alekhya Parvathaneni, Yun-Ling Pai, Andrew L. Koenig, Farid F. Kadyrov, Macee C. Owen, Junedh Amrute, Andrea L. Bredemeyer, Yu-Sung Hsu, Attila Kovacs, Carla J. Weinheimer, Jessica M. Nigro, Lance Yeh, Thomas Williamson, Blake Jardin, , Kory J. Lavine
This study shows that FAP-targeted BiTE(R) molecules, intended to reduce cardiac fibrosis, instead worsen heart function by triggering harmful immune responses.
bioRxiv · Sep 21, 2026 · PreprintImmunology